Research Article
Efficacy and Prognostic Factors of Androgen Deprivation Therapy Combined with Radiation Therapy for Prostate Cancer
Table 1
Between-group comparison of baseline data (n = 47).
| Item | Combined group | Reference group | X2/t | P |
| Mean age (mean ± SD, years) | 63.37 ± 5.47 | 64.08 ± 5.39 | 0.634 | 0.528 | BMI (mean ± SD, kg/m2) | 21.13 ± 4.37 | 21.17 ± 4.41 | 0.046 | 0.964 | Prostate volume (mean ± SD, cm3) | 25.17 ± 3.28 | 25.13 ± 3.34 | 0.060 | 0.952 | Disease duration (mean ± SD, month) | 7.12 ± 2.14 | 7.15 ± 2.18 | 0.069 | 0.945 |
| TNM pathological stage | II | 25 (53.19%) | 28 (59.57%) | 0.389 | 0.533 | III | 17 (36.17%) | 16 (34.04%) | 0.047 | 0.829 | IV | 5 (10.64%) | 3 (6.38%) | 0.593 | 0.441 | Accompanied metastasis | Bone metastasis | 25 (53.19%) | 22 (46.81%) | 0.383 | 0.536 | Lymph node metastasis | 16 (34.04%) | 12 (25.53%) | 0.814 | 0.367 | Viscera metastasis | 6 (12.77%) | 13 (27.66%) | 3.232 | 0.072 | Nationality (n(%)) | | | 0.712 | 0.399 | Han | 43 (91.49%) | 45 (95.74%) | | | Non-Han | 4 (8.51%) | 2 (4.26%) | | |
| ECOG score | 0 points | 23 (48.94%) | 25 (53.19%) | 0.170 | 0.680 | 1 point | 16 (34.04%) | 15 (31.91%) | 0.048 | 0.826 | 2 points | 8 (17.02%) | 7 (14.89%) | 0.079 | 0.778 |
| Degree of differentiation | Poor differentiation | 14 (29.79%) | 17 (36.17%) | 0.433 | 0.510 | Moderate differentiation | 21 (44.68%) | 20 (42.55%) | 0.043 | 0.835 | Well differentiation | 12 (25.53%) | 10 (21.28%) | 0.237 | 0.626 |
| Marital status (n(%)) | Single | 2 (4.26%) | 3 (6.38%) | 0.211 | 0.646 | Married | 41 (87.23%) | 38 (80.85%) | 0.714 | 0.398 | Divorced | 4 (8.51%) | 6 (12.77%) | 0.448 | 0.503 | Place of residence (n(%)) | | | 0.170 | 0.680 | Urban area | 24 (51.06%) | 22 (46.81%) | | | Rural area | 23 (48.94%) | 25 (53.19%) | | |
| Educational degree [n(%)] | Junior college and above | 8 (17.02%) | 10 (21.28%) | 0.275 | 0.600 | Senior high school | 26 (55.32%) | 23 (48.94%) | 0.384 | 0.536 | Junior high school and below | 13 (27.66%) | 14 (29.79%) | 0.052 | 0.820 |
|
|